The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I'd say we already had our extended tree shake. I bought back in today and now hold more HARL than I have ever before.
Admittedly there is a temptation to sell a small slice just in case there is a negative outcome and a dip, but I may just bet the farm on it and hold onto it all.
Regardless, I think the H1 results will have far more of an effect than the IM, We knew what was coming for year results about 6 months ahead, and it still shook the market, likewise we know H1 will be massively improved whatever the exact figures turn out to be.
This really is reassuring. We knew it could be Early September in a best case scenario, but there was always the risk of it dragging on for months, with no indication of exactly when, this is better than what we assumed the best case scenario was.
I imagine some people took money out in anticipation of a slow news month, but now it wouldn't be surprising if money flows back into HARL in the run up to the 31st
The market didn't like it
As I said, you know what they say about buses
https://www.londonstockexchange.com/news-article/HARL/new-aberdeen-subsidiary/16068259
I really feel like I'm betting against the market here. A lack of news has likely contributed to a drift in SP, so what could we want more than tonight's webinar? Can't buy anymore today as I'm 100% all in, but would if I could.
Not sure about an RNS, but I can't see the webinar being something that will drop the SP. Even if it's just spin, It'll be good to know JW is still about. I'd be very surprised if we don't see an uplift on Wednesday, but this is AIM so who knows.